Cargando…
The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta
The aim of this study was to present and evaluate novel oral vaccines, based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum, to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-COV-...
Autores principales: | Keikha, Reza, Hashemi-Shahri, Seyed Mohammad, Jebali, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556360/ https://www.ncbi.nlm.nih.gov/pubmed/34716391 http://dx.doi.org/10.1038/s41598-021-00830-5 |
Ejemplares similares
-
Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer
por: Reebye, Vikash, et al.
Publicado: (2018) -
Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
por: Liu, Yalan, et al.
Publicado: (2023) -
Poly(2-oxazoline)/saRNA
Polyplexes for Targeted and
Nonviral Gene Delivery
por: Hayes, Graham, et al.
Publicado: (2023) -
Biophysical characterization of the structure of a SARS-CoV-2 self-amplifying RNA (saRNA) vaccine
por: Myatt, Daniel P, et al.
Publicado: (2023) -
saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription
por: Portnoy, Victoria, et al.
Publicado: (2016)